Skip to main content
California Medicine logoLink to California Medicine
. 1953 Aug;79(2):99–102.

URINARY TRACT INFECTIONS—Problems in Medical Management

Ernest Jawetz
PMCID: PMC1522012  PMID: 13067022

Abstract

The lesion principally responsible for chronic, or recurrent, urinary tract infection is a focus in the interstitial tissue of the kidney. Most cursory antimicrobial therapy suppresses the manifestations of lower urinary tract involvement but does not eradicate the renal focus. In order to cure rather than merely suppress the infection, it is imperative that, as early as possible, steps be taken to isolate and identify the etiologic microorganism and to determine its sensitivity to antimicrobial agents. Based on this information sufficient amounts of drug should be given for an adequate period (probably at least two weeks) to eradicate the infection within the renal tissue. Such a program would tend to reduce the number of cases in which irreversible renal failure develops from chronic pyelonephritis.

Full text

PDF
99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIRCHALL R., ALEXANDER J. E. Medical aspects of pyelonephritis. Medicine (Baltimore) 1950 Feb;29(1):1–28. doi: 10.1097/00005792-195002000-00001. [DOI] [PubMed] [Google Scholar]
  2. BIRCHALL R. The responsibility of an internist in the treatment of pyelonephritis. J Urol. 1952 Nov;68(5):798–803. doi: 10.1016/S0022-5347(17)68284-3. [DOI] [PubMed] [Google Scholar]
  3. HOPPER J., Jr, JAWETZ E., HINMAN F., Jr Polymyxin B in chronic pyelonephritis: observations on the safety of the drug and on its influence on the renal infection. Am J Med Sci. 1953 Apr;225(4):402–409. [PubMed] [Google Scholar]
  4. HUNTER T. H. Bacterial endocarditis. Am Heart J. 1951 Sep;42(3):472–482. doi: 10.1016/0002-8703(51)90144-5. [DOI] [PubMed] [Google Scholar]
  5. JAWETZ E., GUNNISON J. B. An experimental basis of combined antibiotic action. J Am Med Assoc. 1952 Oct 18;150(7):693–695. doi: 10.1001/jama.1952.63680070011015. [DOI] [PubMed] [Google Scholar]
  6. JAWETZ E. Infections with Pseudomonas aeruginosa treated with polymyxin B. AMA Arch Intern Med. 1952 Jan;89(1):90–98. doi: 10.1001/archinte.1952.00240010100009. [DOI] [PubMed] [Google Scholar]
  7. MANDEL E. E. Renal medullary necrosis. Am J Med. 1952 Sep;13(3):322–327. doi: 10.1016/0002-9343(52)90286-6. [DOI] [PubMed] [Google Scholar]
  8. Pulaski E. J., Baker H. J., Rosenberg M. L., Connell J. F. LABORATORY AND CLINICAL STUDIES OF POLYMYXIN B AND E. J Clin Invest. 1949 Sep;28(5 Pt 1):1028–1031. doi: 10.1172/JCI102134. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES